What Are Patients and Caregivers Talking About? Lung Cancer Biomarkers
What Are Patients and Caregivers Talking About? Lung Cancer Biomarkers By Kathleen Hoffman, PhD, MSPH Since the FDA approved the first targeted treatment for NSCLC in 2003, treatment decisions for NSCLC are increasingly made based on individual genomics.1,2 There are now 20 distinct biomarkers that serve as identification points differentiating cancer cells [...]